SCHEMBL23867485

SCHEMBL23867485

Cc1cc(Nc2ccc(NC(=O)Cc3c[nH]c4ncccc34)cc2)nc(N2CCN(CCO)CC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.46
▸ HCRTR2 O43614 1/20 0.46
▸ SRC P12931 3/20 0.44
▸ DRD3 P35462 5/20 0.44
▸ DRD2 P14416 3/20 0.44
▸ DRD4 P21917 3/20 0.44
▸ HTR1A P08908 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ GFER P55789 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ WNT3A P56704 1/20 0.41
▸ RET P07949 2/20 0.41
▸ ACHE P22303 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867524 0.90 HCRTR1 (0.52) HCRTR1HCRTR2DRD3DRD2DRD4
SCHEMBL23867521 0.79 HTR1A (0.50) SRCDRD3HTR1AALDH1A1HPGD
SCHEMBL23867479 0.79 POLB (0.49) ALDH1A1HPGDTSHRGFERSMN1; SMN2
SCHEMBL30234371 0.77 ROCK1 (0.46) HCRTR1HCRTR2ALDH1A1HPGDSMN1; SMN2
SCHEMBL31094227 0.76 SLC2A1 (0.44) ALDH1A1HPGDRETKDM4ELMNA
SCHEMBL23867578 0.76 HTR1A (0.48) SRCDRD3HTR1AALDH1A1HPGD
SCHEMBL23867468 0.74 HRH3 (0.45) HCRTR1HCRTR2ALDH1A1HPGDTSHR
SCHEMBL23867470 0.73 HRH3 (0.44) HCRTR1HCRTR2ALDH1A1HPGDACHE
SCHEMBL30234700 0.73 HRH3 (0.47) HTR1AALDH1A1HPGDKDM4ELMNA
SCHEMBL23867490 0.73 HRH3 (0.42) HCRTR1HCRTR2SRCDRD3DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback